C
COGT icon

Covestor’s Cogent Biosciences COGT Stock Holding History

Covestor’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
306
+36
+13% +$1.26K 0.01% 1417
2026
Q1 		$10K Buy
270
+252
+1,400% +$9.3K 0.01% 1386
2025
Q4 		$1K Hold
18
– – ﹤0.01% 2015
2025
Q3 		$0 Hold
18
– – ﹤0.01% 2341
2025
Q2 		$0 Buy
18
+7
+64% +$39 ﹤0.01% 2275
2025
Q1 		$0 Hold
11
– – ﹤0.01% 2287
2024
Q4 		$0 Buy
11
+1
+10% +$10 ﹤0.01% 2294
2024
Q3 		$0 Sell
10
-1
-9% -$10 ﹤0.01% 2282
2024
Q2 		$0 Hold
11
– – ﹤0.01% 2296
2024
Q1 		$0 Sell
11
-4
-27% -$25 ﹤0.01% 2297
2023
Q4 		$0 Buy
15
+8
+114% +$61 ﹤0.01% 2205
2023
Q3 		$0 Sell
7
-1
-13% -$12 ﹤0.01% 2177
2023
Q2 		$0 Hold
8
– – ﹤0.01% 2189
2023
Q1 		$0 Hold
8
– – ﹤0.01% 2084
2022
Q4 		$0 Buy
+8
New +$99 ﹤0.01% 2117

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Covestor's COGT Position: Q2 2026 in Review

Covestor increased its Cogent Biosciences (COGT) stake by 13% in Q2 2026, buying an estimated $1.26K and bringing the position to 306 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #1417.

Covestor first reported a position in COGT in Q4 2022 and has held it in 15 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Covestor held 306 shares of Cogent Biosciences worth $12K as of Q2 2026.
  • Covestor bought 36 Cogent Biosciences shares in Q2 2026, an estimated $1.26K.
  • Cogent Biosciences made up 0.01% of Covestor's portfolio in Q2 2026, its #1417 holding.
  • Covestor first reported a position in Cogent Biosciences in Q4 2022 and has held it in 15 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.